Bottles of blood pressure medication have been recalled by regulators over fears of metal contamination. The recalls was issued on Monday (November 16).
The batch affected is stamped PK25110035, with an expiration date of May 2029, Fox News Business reports. It said the medication could have come into contact with metal in its production, potentially making the capsules unsafe to swallow for “the oral cavity, esophagus, stomach, or intestine”.
The capsules are white with black writing stamped on each one.
The company issued a press release alongside the recall published by the US Food and Drug Administration. It said: “Use of product from the affected lot could potentially cause lacerations of soft tissues in the oral cavity, esophagus, stomach, or intestine. The affected lot shared intermediate material suspected to be the source of metal contamination identified in a separate lot that was not released to market.”
Breckenridge added it was unaware of any adverse events in connection with the recall. It issued the following advice to patients: “Consumers should immediately stop taking product from the lot subject to this recall and contact their physician or healthcare provider for medical advice and replacement instructions. Consumers should return any unused portion of the affected product to the pharmacy where it was obtained.
“Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this product. Wholesalers, pharmacies, and other retail entities should check inventory for the recalled lot, quarantine any affected product, and not distribute or dispense the affected product. Entities that further distributed the product should notify their sub-accounts to the retail level.”
The capsules were distributed to pharmacies from October 26 until November 4, the company added.
This story originally appeared on Express.co.uk
